Home › Alzheimer's Disease › Texas › Round Rock
Alzheimer's Disease clinical trials in Round Rock, TX
4 studies for Alzheimer's Disease are looking for participants at sites in and around Round Rock (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- Central Texas Neurology Consultants, Round Rock
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
RecruitingPhase 3
- Central Texas Neurology Consultants, PA, Round Rock
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
RecruitingPhase 2
- Be Well Clinical Studies, Round Rock
[18F]PI-2620 Phase 3 Histopathological Study
RecruitingPhase 3
- Be Well Clinical Studies, Round Rock
About Alzheimer's Disease
Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.
More about Alzheimer's Disease on MedlinePlus
Alzheimer's Disease trials in other cities
- Boston, MA26 studies
- Orlando, FL25 studies
- St. Louis, MO22 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Tampa, FL17 studies
- Atlanta, GA16 studies
- Philadelphia, PA15 studies
- The Villages, FL15 studies
- Phoenix, AZ15 studies
- Indianapolis, IN14 studies
- Los Angeles, CA14 studies
Other studies in Round Rock
- Parkinson's Disease9 studies
- Ulcerative Colitis8 studies
- Crohn's Disease7 studies
- Steatotic Liver Disease7 studies
- Inflammatory Bowel Disease5 studies
- Type 2 Diabetes4 studies
- Non-Small Cell Lung Cancer4 studies
- Obesity4 studies
- Liver Diseases3 studies
- Colorectal Cancer3 studies
- Mild Cognitive Impairment3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.